| Literature DB >> 24416391 |
Douglas P Gladue1, Ryan Baker-Bransetter2, Lauren G Holinka2, Ignacio J Fernandez-Sainz2, Vivian O'Donnell1, Paige Fletcher2, Zhiqiang Lu3, Manuel V Borca2.
Abstract
E2 is one of the envelope glycoproteins of pestiviruses, including classical swine fever virus (CSFV) and bovine viral diarrhea virus (BVDV). E2 is involved in several critical functions, including virus entry into target cells, induction of a protective immune response and virulence in swine. However, there is no information regarding any host binding partners for the E2 proteins. Here, we utilized the yeast two-hybrid system and identified fifty-seven host proteins as positive binding partners which bound E2 from both CSFV and BVDV with the exception of two proteins that were found to be positive for binding only to CSFV E2. Alanine scanning of CSFV E2 demonstrated that the binding sites for these cellular proteins on E2 are likely non-linear binding sites. The possible roles of the identified host proteins are discussed as the results presented here will be important for future studies to elucidate mechanisms of host protein-virus interactions during pestivirus infection. However, due to the limitations of the yeast two hybrid system, the proteins identified is not exhaustive and each interaction identified needs to be confirmed by independent experimental approaches in the context of virus-infected cells before any definitive conclusion can be drawn on relevance for the virus life cycle.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24416391 PMCID: PMC3885694 DOI: 10.1371/journal.pone.0085324
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Multiple sequence alignment using Bioedit software was performed using CSFV E2 from the Brescia isolate (GenBank Accession #AF091661) and the BVDV E2 from the NADL isolate (GenBank Accession #AJ133738.1).
Proteins that interact with CSFV+BVDV E2.
| Gene symbol | Gene Name | Gene symbol | Gene Name |
| ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain | NDUFS1 | NADH dehydrogenase (ubiquinone) Fe-S protein 1,75 kDa |
| ALDH7A1 | alpha-aminoadipic semialdehyde dehydrogenase-like | NUP43 | nucleoporin 43 kDa |
| CAPZA2 | capping protein (actin filament) muscle Z-line, alpha 2 | PELI1 | E3 ubiquitin-protein ligase pellino homolog 1 |
| CCDC115 | coiled-coil domain-containing protein 115-like | PHC3 | polyhomeotic homolog 3 (Drosophila) |
| CCDC80 | coiled-coil domain containing 80 | POFUT2 | protein O-fucosyltransferase 2 |
| CCT7 | chaperonin containing TCP1, subunit 7 | POMP | proteasome maturation protein |
| CEP57 | centrosomal protein of 57 kDa | PPT1 | palmitoyl-protein thioesterase 1 |
| CFP | complement factor properdin | PRDX3 | thioredoxin-dependent peroxide reductase, mitochondrial |
| CTSB | cathepsin B | PRMT10 | protein arginine methyltransferase 10 |
| CTSH | cathepsin H | QARS | glutaminyl-tRNA synthetase |
| DCTN6 | dynactin 6 | RMD5 | required for meiotic nuclear division 5 homolog B |
| DOCK7 | dedicator of cytokinesis 7 | SDCBP | syndecan binding protein (syntenin) |
| EIF6 | eukaryotic translation initiation factor 6 | SERTAD1 | SERTA domain-containing 1 |
| EMID1 | EMI domain containing 1 | SERTAD3 | SERTA domain-containing protein 3 |
| FANCF | fanconi anemia, complementation group F | SIVA1 | apoptosis-inducing factor |
| FANCL | fanconi anemia, complementation group L | SPG11 | spastic paraplegia 11 |
| FBLN5 | fibulin 5 | TARDBP | TAR DNA-binding protein 43 |
| FLNA | filamin A, alpha | TBL1XR1 | transducin (beta)-like 1 X-linked receptor 1 isoform 2 |
| GCA | grancalcin-like | TCEB1 | transcription elongation factor B (SIII), polypeptide 1 |
| GCH1 | GTP cyclohydrolase 1 | TOR1AIP2 | torsin A interacting protein 2 |
| HGPRT | hypoxanthine phosphoribosyltransferase 1 | TRAPPC2 | trafficking protein particle complex 2 |
| HMCN1 | hemicentin 1 | TRAPPC8 | trafficking protein particle complex 8 |
| KLHL20 | kelch-like 20 isoform CRA_c | TXN2 | thioredoxin |
| LGALS3 | lectin, galactoside-binding, soluble, 3 | UPF0712 | C7orf64 homolog |
| LTBP1 | latent transforming growth factor beta binding protein 1 | UPF1 | regulator of nonsense transcripts homolog |
| MAGOHB | mago-nashi homolog B | UXT | Ubiquitously-expressed transcript |
| MRPL45 | mitochondrial ribosomal protein L45 | VCAN | Versican |
| NCF2 | neutrophil cytosol factor 2 |
proteins discovered in the swine library. All other proteins discovered in the bovine library.
Host proteins exclusively binding CSFV E2.
| Gene symbol | Gene Name |
| HNRPF | heterogeneous nuclear ribonucleoprotein F isoform 5 |
| PTBP2 | polypyrimidine tract-binding protein 2 |
proteins discovered in the swine library.
Figure 2A graphic view of the distribution of E2 positive interacting proteins, as separated into Biological processes, as defined by the PANTHER classification system.
Biological process classification of E2 interacting proteins by PANTHER analysis.
| Biological Process | Definition | Proteins Identified |
| Metabolic processes: | Any process involving chemical reactions and pathways, bywhich living organisms transform chemical substances. | CTSH, GCH1, PPT1, CCDC80, EIF6, PHC3, TCEB1, PRDX3,CCT7, HGPRT, KLHL20, MAGOHB, FBLN5, TXN2, ACADM,DCTN6, QARS, ALDH7A1, PRMT10, TARDBP, UXT |
| Cellular processes | Any process that is carried out at the cellular level | CCDC80, PHC3, CAPZA2, HMCN1, KLHL20, LGALS3, DOCK7,FLNA, FBLN5, LTBP1, TXN2, VCAN, TARDBP |
| Developmental Processes: | Any process whose specific outcome is the progression ofan integrated living unit that develops froman initial condition to a later condition | PHC3, CAPZA2, HMCN1, KLHL20, FLNA, MAGOHB, FBLN5,LTBP1, VCAN, TARDBP |
| Immune System processes: | Any process involved in the development orfunctioning of the immune system | CFP, CTSH, CCDC80, NCF2, PRDX3, LGALS3, FBLN5,TXN2 |
| Cell Communication: | Any process that mediates interactions betweena cell and its surroundings | CCDC80, DOCK7, FLNA, FBLN5, LTBP1,TXN2, VCAN |
| Cell Adhesion: | Any process involved in the attachment of a cell,either to another cell or to an underlying substrate | CDC80, HMCN1, LGALS3, FLNA, FBLN5,VCAN |
| System process: | A multicellular organismal process carried out byany of the organs or tissues in an organ system | HMCN1, KLHL20, FLNA, FBLN5, LTBP1 |
| Response to stimulus: | Any process that involves a change in state oractivity of a cell or an organism as a result of a stimulus. | CFP, CTSH, CCDC80, NCF2, TXN2 |
| Cellular componentorganization: | A process that is carried out at the cellular levelwhich results in the assembly, arrangement of constituentparts, or disassembly of acellular component | PHC3, CAPZA2, KLHL20, FLNA |
| Cell cycle: | The progression of biochemical and morphologicalphases and events that occur in a cell during successivecell replication or nuclearreplication events. | PHC3, FLNA, TXN2, TARDBP |
| Transport: | Processes involved in the movement of substancesinto, out of, within or between cells, or within amulticellular organism | TRAPPC8, DOCK7, SDCBP |
| Generation of precursormetabolites andenergy: | The chemical reactions and pathways resulting inthe formation of precursor metabolites, substances fromwhich energy is derived, and any process involved inthe liberation of energy from these substances | NDUFS1, TXN2, ACADM |
| Apoptosis: | Any process that is involved in a form ofprogrammed cell death | LGALS3, TXN2 |
| Localization: | Any process by which a cell, a substance, ora cellular entity, is transported to, and/or maintained ina specific location | MAGOHB |
| Reproduction | Processes involved in production by an organismof new individuals that contain some portion of theirgenetic material inherited fromthat organism | MAGOHB |
Figure 3Scheme showing CSFV E2 alanine mutants used in the present study.
All indicated residues were mutated to an alanine.